Methods and Systems for Ablation of the Renal Pelvis

ChangeBridge: Patent Apps - Pharma (A61K)

Published April 2nd, 2026

Detected April 2nd, 2026

Summary

Verve Medical, Inc. filed a patent application (US20260091000A1) with the USPTO on April 2, 2026 for methods and systems of renal pelvis ablation to treat renal nerves. The application covers apparatus and systems for delivering heat or extracting heat through the renal pelvis wall, or delivering active substances to ablate tissue lining. Inventors include Terrence J. Buelna, Adam Gold, and Rahul Rao.

View original document View source feed page

What changed

Verve Medical, Inc. published a patent application (US20260091000A1) for methods and systems providing access to the renal pelvis of a kidney to treat renal nerves embedded in surrounding tissue. The invention covers access via the urinary tract or minimally invasive abdominal incisions, with treatment effects achieved by exchanging energy (delivering or extracting heat) through the renal pelvis wall, or by delivering active substances to ablate a thin layer of tissue lining to disrupt renal nerves.

This patent publication notifies competitors and researchers in the medical device and healthcare sectors of pending claims. Companies developing similar ablation devices or renal nerve treatment methods should review the claim scope to assess potential overlap with their own R&D activities. No compliance deadlines apply as this is a patent publication rather than a regulatory requirement.

Source document (simplified)

← USPTO Patent Applications

METHODS AND SYSTEMS FOR ABLATION OF THE RENAL PELVIS

Application US20260091000A1 Kind: A1 Apr 02, 2026

Assignee

Verve Medical, Inc.

Inventors

Terrence J. Buelna, Adam Gold, Rahul Rao

Abstract

Apparatus, systems, and methods provide access to the renal pelvis of a kidney to treat renal nerves embedded in tissue surrounding the renal pelvis. Access to the renal pelvis may be via the urinary tract or via minimally invasive incisions through the abdomen and kidney tissue. Treatment is effected by exchanging energy, typically delivering heat or extracting heat through a wall of the renal pelvis, or by delivering active substances to ablate a thin layer of tissue lining at least a portion of the renal pelvis to disrupt renal nerves within the tissue lining of the renal pelvis

CPC Classifications

A61K 31/045 A61B 18/1492 A61B 2017/320008 A61B 2017/320069 A61B 2018/00214 A61B 2018/0022 A61B 2018/00267 A61B 2018/00434 A61B 2018/00511 A61B 2018/00577 A61B 2018/00797 A61B 2018/00821 A61B 2018/044 A61B 2018/1417 A61B 2018/1435 A61B 2018/1861 A61N 1/325 A61N 7/022